25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AJANTA PHARMA LTD.
Buy, Hold or Sell?

Let's analyze AJANTA PHARMA LTD. together

I guess you are interested in AJANTA PHARMA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AJANTA PHARMA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about AJANTA PHARMA LTD.

I send you an email if I find something interesting about AJANTA PHARMA LTD..

1. Quick Overview

1.1. Quick analysis of AJANTA PHARMA LTD. (30 sec.)










1.2. What can you expect buying and holding a share of AJANTA PHARMA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR2.43
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR283.30
Expected worth in 1 year
INR340.22
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR260.92
Return On Investment
9.1%

For what price can you sell your share?

Current Price per Share
INR2,855.40
Expected price per share
INR2,356 - INR3,044
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of AJANTA PHARMA LTD. (5 min.)




Live pricePrice per Share (EOD)
INR2,855.40
Intrinsic Value Per Share
INR499.59 - INR800.89
Total Value Per Share
INR782.89 - INR1,084.19

2.2. Growth of AJANTA PHARMA LTD. (5 min.)




Is AJANTA PHARMA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$424.4m$403.1m$21.3m5.0%

How much money is AJANTA PHARMA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$97.1m$69.9m$27.1m28.0%
Net Profit Margin19.6%15.7%--

How much money comes from the company's main activities?

2.3. Financial Health of AJANTA PHARMA LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of AJANTA PHARMA LTD.?

Welcome investor! AJANTA PHARMA LTD.'s management wants to use your money to grow the business. In return you get a share of AJANTA PHARMA LTD..

First you should know what it really means to hold a share of AJANTA PHARMA LTD.. And how you can make/lose money.

Speculation

The Price per Share of AJANTA PHARMA LTD. is INR2,855. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AJANTA PHARMA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AJANTA PHARMA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR283.30. Based on the TTM, the Book Value Change Per Share is INR14.23 per quarter. Based on the YOY, the Book Value Change Per Share is INR16.55 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR51.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AJANTA PHARMA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.770.0%0.770.0%0.560.0%0.610.0%0.520.0%
Usd Book Value Change Per Share0.170.0%0.170.0%0.200.0%0.250.0%0.370.0%
Usd Dividend Per Share0.610.0%0.610.0%0.080.0%0.190.0%0.140.0%
Usd Total Gains Per Share0.780.0%0.780.0%0.280.0%0.440.0%0.510.0%
Usd Price Per Share24.80-24.80-14.41-19.37-18.42-
Price to Earnings Ratio32.16-32.16-25.92-31.42-35.46-
Price-to-Total Gains Ratio31.95-31.95-51.13-48.97-43.83-
Price to Book Ratio7.36-7.36-4.50-6.49-8.49-
Price-to-Total Gains Ratio31.95-31.95-51.13-48.97-43.83-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share33.97926
Number of shares29
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.610.19
Usd Book Value Change Per Share0.170.25
Usd Total Gains Per Share0.780.44
Gains per Quarter (29 shares)22.5112.67
Gains per Year (29 shares)90.0450.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1702080222941
214139170445792
3211592606686143
42827935088114194
535298440110143245
6422118530132172296
7493137620155200347
8563157710177229398
9634177800199257449
10704196890221286500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of AJANTA PHARMA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--14.23014.2300%16.555-14%20.711-31%31.478-55%
Book Value Per Share--283.300283.3000%269.070+5%248.747+14%200.860+41%
Current Ratio--3.0493.0490%2.480+23%2.972+3%3.101-2%
Debt To Asset Ratio--0.2310.2310%0.276-16%0.225+3%0.201+15%
Debt To Equity Ratio--0.3000.3000%0.381-21%0.292+3%0.255+18%
Dividend Per Share--51.00051.0000%7.123+616%15.990+219%11.698+336%
Eps--64.81964.8190%46.697+39%50.893+27%44.090+47%
Free Cash Flow Per Share--50.24550.2450%49.024+2%35.962+40%23.474+114%
Free Cash Flow To Equity Per Share--50.24550.2450%40.458+24%20.168+149%10.548+376%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--800.894--------
Intrinsic Value_10Y_min--499.587--------
Intrinsic Value_1Y_max--51.732--------
Intrinsic Value_1Y_min--39.922--------
Intrinsic Value_3Y_max--177.172--------
Intrinsic Value_3Y_min--129.443--------
Intrinsic Value_5Y_max--328.820--------
Intrinsic Value_5Y_min--228.682--------
Market Cap356673724800.000+26%262458591282.000262458591282.0000%152425991663.000+72%207539935898.738+26%195692557297.521+34%
Net Profit Margin--0.1960.1960%0.157+25%0.195+1%0.208-6%
Operating Margin----0%0.179-100%0.192-100%0.200-100%
Operating Ratio--1.0171.0170%1.124-10%1.0220%0.908+12%
Pb Ratio10.079+27%7.3587.3580%4.499+64%6.495+13%8.489-13%
Pe Ratio44.052+27%32.15732.1570%25.924+24%31.420+2%35.458-9%
Price Per Share2855.400+27%2084.4002084.4000%1210.550+72%1627.809+28%1547.932+35%
Price To Free Cash Flow Ratio56.830+27%41.48541.4850%24.693+68%48.908-15%243.513-83%
Price To Total Gains Ratio43.775+27%31.95531.9550%51.126-37%48.971-35%43.828-27%
Quick Ratio--1.7601.7600%2.113-17%2.003-12%2.224-21%
Return On Assets--0.1760.1760%0.126+40%0.158+11%0.187-6%
Return On Equity--0.2290.2290%0.174+32%0.204+12%0.233-2%
Total Gains Per Share--65.23065.2300%23.678+175%36.702+78%43.176+51%
Usd Book Value--424495610.000424495610.0000%403170810.000+5%376373676.000+13%302248761.111+40%
Usd Book Value Change Per Share--0.1690.1690%0.197-14%0.246-31%0.375-55%
Usd Book Value Per Share--3.3713.3710%3.202+5%2.960+14%2.390+41%
Usd Dividend Per Share--0.6070.6070%0.085+616%0.190+219%0.139+336%
Usd Eps--0.7710.7710%0.556+39%0.606+27%0.525+47%
Usd Free Cash Flow--75286540.00075286540.0000%73457510.000+2%54387760.000+38%35410565.556+113%
Usd Free Cash Flow Per Share--0.5980.5980%0.583+2%0.428+40%0.279+114%
Usd Free Cash Flow To Equity Per Share--0.5980.5980%0.481+24%0.240+149%0.126+376%
Usd Market Cap4244417325.120+26%3123257236.2563123257236.2560%1813869300.790+72%2469725237.195+26%2328741431.841+34%
Usd Price Per Share33.979+27%24.80424.8040%14.406+72%19.371+28%18.420+35%
Usd Profit--97124230.00097124230.0000%69969620.000+39%77074158.000+26%66328748.889+46%
Usd Revenue--495229210.000495229210.0000%445374160.000+11%398002164.000+24%326060264.444+52%
Usd Total Gains Per Share--0.7760.7760%0.282+175%0.437+78%0.514+51%
 EOD+4 -4MRQTTM+0 -0YOY+26 -95Y+25 -1010Y+22 -13

3.3 Fundamental Score

Let's check the fundamental score of AJANTA PHARMA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.052
Price to Book Ratio (EOD)Between0-110.079
Net Profit Margin (MRQ)Greater than00.196
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.760
Current Ratio (MRQ)Greater than13.049
Debt to Asset Ratio (MRQ)Less than10.231
Debt to Equity Ratio (MRQ)Less than10.300
Return on Equity (MRQ)Greater than0.150.229
Return on Assets (MRQ)Greater than0.050.176
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of AJANTA PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.563
Ma 20Greater thanMa 503,050.733
Ma 50Greater thanMa 1003,182.639
Ma 100Greater thanMa 2002,893.459
OpenGreater thanClose2,851.050
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About AJANTA PHARMA LTD.

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-10-27 00:29:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit AJANTA PHARMA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 19.6% means that ₹0.20 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AJANTA PHARMA LTD.:

  • The MRQ is 19.6%. The company is making a huge profit. +2
  • The TTM is 19.6%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.6%TTM19.6%0.0%
TTM19.6%YOY15.7%+3.9%
TTM19.6%5Y19.5%+0.1%
5Y19.5%10Y20.8%-1.3%
4.3.1.2. Return on Assets

Shows how efficient AJANTA PHARMA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.6% Return on Assets means that AJANTA PHARMA LTD. generated ₹0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AJANTA PHARMA LTD.:

  • The MRQ is 17.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 17.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.6%TTM17.6%0.0%
TTM17.6%YOY12.6%+5.0%
TTM17.6%5Y15.8%+1.8%
5Y15.8%10Y18.7%-2.8%
4.3.1.3. Return on Equity

Shows how efficient AJANTA PHARMA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 22.9% Return on Equity means AJANTA PHARMA LTD. generated ₹0.23 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AJANTA PHARMA LTD.:

  • The MRQ is 22.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 22.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ22.9%TTM22.9%0.0%
TTM22.9%YOY17.4%+5.5%
TTM22.9%5Y20.4%+2.5%
5Y20.4%10Y23.3%-2.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of AJANTA PHARMA LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient AJANTA PHARMA LTD. is operating .

  • Measures how much profit AJANTA PHARMA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AJANTA PHARMA LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY17.9%-17.9%
TTM-5Y19.2%-19.2%
5Y19.2%10Y20.0%-0.8%
4.3.2.2. Operating Ratio

Measures how efficient AJANTA PHARMA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.02 means that the operating costs are ₹1.02 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 1.017. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.017. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.017TTM1.0170.000
TTM1.017YOY1.124-0.107
TTM1.0175Y1.022-0.005
5Y1.02210Y0.908+0.113
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of AJANTA PHARMA LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if AJANTA PHARMA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.05 means the company has ₹3.05 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 3.049. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.049. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.049TTM3.0490.000
TTM3.049YOY2.480+0.569
TTM3.0495Y2.972+0.077
5Y2.97210Y3.101-0.129
4.4.3.2. Quick Ratio

Measures if AJANTA PHARMA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.76 means the company can pay off ₹1.76 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 1.760. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.760. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.760TTM1.7600.000
TTM1.760YOY2.113-0.353
TTM1.7605Y2.003-0.242
5Y2.00310Y2.224-0.221
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of AJANTA PHARMA LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of AJANTA PHARMA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AJANTA PHARMA LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.23 means that AJANTA PHARMA LTD. assets are financed with 23.1% credit (debt) and the remaining percentage (100% - 23.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 0.231. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.231. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.231TTM0.2310.000
TTM0.231YOY0.276-0.045
TTM0.2315Y0.225+0.006
5Y0.22510Y0.201+0.024
4.5.4.2. Debt to Equity Ratio

Measures if AJANTA PHARMA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 30.0% means that company has ₹0.30 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 0.300. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.300. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.300TTM0.3000.000
TTM0.300YOY0.381-0.081
TTM0.3005Y0.292+0.008
5Y0.29210Y0.255+0.038
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings AJANTA PHARMA LTD. generates.

  • Above 15 is considered overpriced but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 32.16 means the investor is paying ₹32.16 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 44.052. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.157. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.157. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.052MRQ32.157+11.895
MRQ32.157TTM32.1570.000
TTM32.157YOY25.924+6.234
TTM32.1575Y31.420+0.738
5Y31.42010Y35.458-4.038
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 56.830. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 41.485. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 41.485. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD56.830MRQ41.485+15.345
MRQ41.485TTM41.4850.000
TTM41.485YOY24.693+16.792
TTM41.4855Y48.908-7.423
5Y48.90810Y243.513-194.605
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of AJANTA PHARMA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 7.36 means the investor is paying ₹7.36 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 10.079. Based on the equity, the company is expensive. -2
  • The MRQ is 7.358. Based on the equity, the company is overpriced. -1
  • The TTM is 7.358. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.079MRQ7.358+2.721
MRQ7.358TTM7.3580.000
TTM7.358YOY4.499+2.859
TTM7.3585Y6.495+0.863
5Y6.49510Y8.489-1.994
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets46,383,900
Total Liabilities10,712,000
Total Stockholder Equity35,671,900
 As reported
Total Liabilities 10,712,000
Total Stockholder Equity+ 35,671,900
Total Assets = 46,383,900

Assets

Total Assets46,383,900
Total Current Assets27,309,200
Long-term Assets19,074,700
Total Current Assets
Cash And Cash Equivalents 1,294,900
Short-term Investments 3,300,500
Net Receivables 12,468,400
Inventory 8,283,600
Other Current Assets 1,330,700
Total Current Assets  (as reported)27,309,200
Total Current Assets  (calculated)26,678,100
+/- 631,100
Long-term Assets
Property Plant Equipment 17,209,800
Intangible Assets 146,600
Long-term Assets Other 94,400
Long-term Assets  (as reported)19,074,700
Long-term Assets  (calculated)17,450,800
+/- 1,623,900

Liabilities & Shareholders' Equity

Total Current Liabilities8,957,600
Long-term Liabilities1,754,400
Total Stockholder Equity35,671,900
Total Current Liabilities
Short Long Term Debt 14,900
Accounts payable 4,632,000
Other Current Liabilities 597,300
Total Current Liabilities  (as reported)8,957,600
Total Current Liabilities  (calculated)5,244,200
+/- 3,713,400
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt337,900
Long-term Liabilities Other 1,700
Long-term Liabilities  (as reported)1,754,400
Long-term Liabilities  (calculated)339,600
+/- 1,414,800
Total Stockholder Equity
Retained Earnings 33,143,500
Total Stockholder Equity (as reported)35,671,900
Total Stockholder Equity (calculated)33,143,500
+/- 2,528,400
Other
Capital Stock252,700
Common Stock Shares Outstanding 125,916
Net Invested Capital 35,686,800
Net Working Capital 18,351,600
Property Plant and Equipment Gross 26,020,200



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
14,879,600
18,477,000
24,485,900
26,961,800
33,186,900
37,787,200
40,555,800
46,790,200
46,383,900
46,383,90046,790,20040,555,80037,787,20033,186,90026,961,80024,485,90018,477,00014,879,600
   > Total Current Assets 
7,632,700
8,506,000
12,236,200
11,798,100
16,417,100
20,275,900
22,644,600
28,251,800
27,309,200
27,309,20028,251,80022,644,60020,275,90016,417,10011,798,10012,236,2008,506,0007,632,700
       Cash And Cash Equivalents 
0
519,400
906,400
951,600
2,023,500
1,775,100
2,063,700
3,298,300
1,294,900
1,294,9003,298,3002,063,7001,775,1002,023,500951,600906,400519,4000
       Short-term Investments 
0
1,815,600
1,848,300
647,400
671,400
2,006,700
1,218,600
5,102,700
3,300,500
3,300,5005,102,7001,218,6002,006,700671,400647,4001,848,3001,815,6000
       Net Receivables 
3,723,500
3,281,200
5,726,700
5,493,700
7,753,000
7,384,300
10,198,100
10,569,000
12,468,400
12,468,40010,569,00010,198,1007,384,3007,753,0005,493,7005,726,7003,281,2003,723,500
       Inventory 
2,073,300
2,110,200
3,506,300
4,357,100
4,956,800
7,664,700
7,910,700
8,156,300
8,283,600
8,283,6008,156,3007,910,7007,664,7004,956,8004,357,1003,506,3002,110,2002,073,300
       Other Current Assets 
23,400
611,800
243,700
231,300
232,100
364,200
573,700
10,700
1,330,700
1,330,70010,700573,700364,200232,100231,300243,700611,80023,400
   > Long-term Assets 
0
9,761,000
12,249,700
15,149,500
16,769,800
17,511,300
17,911,200
18,450,200
19,074,700
19,074,70018,450,20017,911,20017,511,30016,769,80015,149,50012,249,7009,761,0000
       Property Plant Equipment 
6,854,000
9,211,900
11,065,400
14,233,100
15,829,000
16,296,100
16,474,200
16,981,600
17,209,800
17,209,80016,981,60016,474,20016,296,10015,829,00014,233,10011,065,4009,211,9006,854,000
       Intangible Assets 
51,400
72,400
74,500
66,500
117,100
107,900
90,200
77,500
146,600
146,60077,50090,200107,900117,10066,50074,50072,40051,400
       Long-term Assets Other 
0
400
0
100
0
139,200
65,400
53,200
94,400
94,40053,20065,400139,200010004000
> Total Liabilities 
2,971,000
2,800,100
4,072,200
4,509,700
7,198,200
7,830,900
7,912,400
12,910,300
10,712,000
10,712,00012,910,3007,912,4007,830,9007,198,2004,509,7004,072,2002,800,1002,971,000
   > Total Current Liabilities 
2,598,900
2,466,600
3,460,500
3,776,400
6,061,700
6,486,300
6,473,900
11,392,800
8,957,600
8,957,60011,392,8006,473,9006,486,3006,061,7003,776,4003,460,5002,466,6002,598,900
       Short-term Debt 
462,500
0
0
333,400
428,500
0
0
0
0
0000428,500333,40000462,500
       Short Long Term Debt 
0
57,700
7,900
353,000
449,400
900
2,700
1,800
14,900
14,9001,8002,700900449,400353,0007,90057,7000
       Accounts payable 
0
1,781,800
2,496,300
2,251,800
3,623,400
3,738,600
3,271,700
4,227,700
4,632,000
4,632,0004,227,7003,271,7003,738,6003,623,4002,251,8002,496,3001,781,8000
       Other Current Liabilities 
0
464,700
676,100
763,900
1,520,600
2,215,800
2,666,800
6,930,600
597,300
597,3006,930,6002,666,8002,215,8001,520,600763,900676,100464,7000
   > Long-term Liabilities 
0
316,100
611,700
733,300
1,136,500
1,344,600
1,438,500
1,517,500
1,754,400
1,754,4001,517,5001,438,5001,344,6001,136,500733,300611,700316,1000
       Long term Debt Total 
148,700
10,400
10,100
6,600
127,100
197,700
185,700
262,000
0
0262,000185,700197,700127,1006,60010,10010,400148,700
       Other Liabilities 
0
323,100
601,600
726,700
1,009,400
1,146,900
1,252,800
0
0
001,252,8001,146,9001,009,400726,700601,600323,1000
> Total Stockholder Equity
11,908,600
15,676,900
20,413,700
22,452,100
25,988,700
29,956,300
32,643,400
33,879,900
35,671,900
35,671,90033,879,90032,643,40029,956,30025,988,70022,452,10020,413,70015,676,90011,908,600
   Common Stock
176,900
176,000
176,000
174,500
174,500
173,000
170,800
252,700
0
0252,700170,800173,000174,500174,500176,000176,000176,900
   Retained Earnings 
10,915,600
14,670,300
19,356,700
22,206,900
25,683,600
29,725,600
32,494,700
33,527,500
33,143,500
33,143,50033,527,50032,494,70029,725,60025,683,60022,206,90019,356,70014,670,30010,915,600
   Capital Surplus 
759,900
760,600
774,200
0
10,600
0
0
0
0
000010,6000774,200760,600759,900
   Treasury Stock000000000
   Other Stockholders Equity 
53,500
70,000
106,800
70,700
120,000
57,700
-22,100
96,300
0
096,300-22,10057,700120,00070,700106,80070,00053,500



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue41,615,900
Cost of Revenue-11,153,200
Gross Profit30,462,70030,462,700
 
Operating Income (+$)
Gross Profit30,462,700
Operating Expense-31,159,500
Operating Income10,456,400-696,800
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,826,600
Selling And Marketing Expenses0
Operating Expense31,159,5003,826,600
 
Net Interest Income (+$)
Interest Income277,100
Interest Expense-72,100
Other Finance Cost-0
Net Interest Income205,000
 
Pretax Income (+$)
Operating Income10,456,400
Net Interest Income205,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)11,139,30010,456,400
EBIT - interestExpense = -72,100
8,161,700
8,233,800
Interest Expense72,100
Earnings Before Interest and Taxes (EBIT)011,211,400
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax11,139,300
Tax Provision-2,977,600
Net Income From Continuing Ops8,161,7008,161,700
Net Income8,161,700
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-205,000
 

Technical Analysis of AJANTA PHARMA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AJANTA PHARMA LTD.. The general trend of AJANTA PHARMA LTD. is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AJANTA PHARMA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AJANTA PHARMA LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2,891 < 2,899 < 3,044.

The bearish price targets are: 2,397 > 2,394 > 2,356.

Tweet this
AJANTA PHARMA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AJANTA PHARMA LTD.. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AJANTA PHARMA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AJANTA PHARMA LTD.. The current macd is -66.49049337.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AJANTA PHARMA LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for AJANTA PHARMA LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the AJANTA PHARMA LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AJANTA PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartAJANTA PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AJANTA PHARMA LTD.. The current adx is 23.83.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell AJANTA PHARMA LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
AJANTA PHARMA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AJANTA PHARMA LTD.. The current sar is 3,171.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AJANTA PHARMA LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AJANTA PHARMA LTD.. The current rsi is 36.56. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
AJANTA PHARMA LTD. Daily Relative Strength Index (RSI) ChartAJANTA PHARMA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AJANTA PHARMA LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AJANTA PHARMA LTD. price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
AJANTA PHARMA LTD. Daily Stochastic Oscillator ChartAJANTA PHARMA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AJANTA PHARMA LTD.. The current cci is -134.75290674.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
AJANTA PHARMA LTD. Daily Commodity Channel Index (CCI) ChartAJANTA PHARMA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AJANTA PHARMA LTD.. The current cmo is -34.85391824.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AJANTA PHARMA LTD. Daily Chande Momentum Oscillator (CMO) ChartAJANTA PHARMA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AJANTA PHARMA LTD.. The current willr is -88.76017101.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
AJANTA PHARMA LTD. Daily Williams %R ChartAJANTA PHARMA LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AJANTA PHARMA LTD..

AJANTA PHARMA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AJANTA PHARMA LTD.. The current atr is 118.66.

AJANTA PHARMA LTD. Daily Average True Range (ATR) ChartAJANTA PHARMA LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AJANTA PHARMA LTD.. The current obv is -890,500.

AJANTA PHARMA LTD. Daily On-Balance Volume (OBV) ChartAJANTA PHARMA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AJANTA PHARMA LTD.. The current mfi is 52.47.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
AJANTA PHARMA LTD. Daily Money Flow Index (MFI) ChartAJANTA PHARMA LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AJANTA PHARMA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

AJANTA PHARMA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AJANTA PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.563
Ma 20Greater thanMa 503,050.733
Ma 50Greater thanMa 1003,182.639
Ma 100Greater thanMa 2002,893.459
OpenGreater thanClose2,851.050
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of AJANTA PHARMA LTD. with someone you think should read this too:
  • Are you bullish or bearish on AJANTA PHARMA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AJANTA PHARMA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AJANTA PHARMA LTD.

I send you an email if I find something interesting about AJANTA PHARMA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about AJANTA PHARMA LTD..

Receive notifications about AJANTA PHARMA LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.